Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy.
Ivano RivaEleonora MichelettiRiccardo FaustoCarlo BruttiniGiovanni De AngelisRoberto CeccuzziLuciano QuarantaPublished in: European journal of ophthalmology (2021)
Cenegermin was extremely effective in restoring corneal integrity in this PCG patient with NK.